| TRADING CENTER |
| OncoGenex Slammed on Teva Parnership: BioBuzz - at TheStreet.com | |
| Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 t... - PR Newswire | |
| These 5 Underdogs Are No Dogs - MotleyFool.com | |
| Regulus Therapeutics Receives Exclusive License for Intellectual Property on Immuno-i... - Business Wire | |
| Isis and Alnylam Announce Notice of Allowance for New U.S. Patent Application Broadly... - Business Wire | |
| 4-Star Stocks Poised to Pop: Isis Pharmaceuticals - MotleyFool.com | |
| 3 Stocks Hitting Low Notes - MotleyFool.com | |
| Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline - PR Newswire | |
| Isis Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conferen... - PR Newswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.22 | 0.49 / 0.86% | 10.94 |
| GILD | Gilead Sciences Inc | 43.24 | 0.08 / 0.19% | 16.69 |
| CELG | Celgene Corporation | 56.29 | 0.20 / 0.36% | 67.82 |
| 2008 Revenue: | $107.2 M | Headquarters: Carlsbad, CA |
| Employees: | 300 | CEO: Dr. Stanley T. Crooke, M.D., Ph.D. |
| Net Income: | $-11,963,000.0 | Industry: Biotechnology |
| Market Cap: | $987.7 M | Website: www.isispharm.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| ISIS | 10.44 | +0.40 / +3.98% | 10.04 | 10.47 | 10.03 | Profile Chart News |